Back to Trials
NCT05978466Recruiting

MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)

CorVita Science Foundation

Start Date

12/22/2017

Completion Date

12/31/2027

Summary

The purpose of this research is to learn more about the normal care of patients with a new or pre-existing diagnosis of atrial fibrillation (AF). These abnormal and irregular heartbeats place patients at increased risk of developing clots in their bloodstream that could potentially lead to stroke. Normal care is designed to help prevent this from happening and to lessen or eliminate the symptoms patients may have. There are many different types of AF as well as numerous ways in which a variety of patients are treated. The investigators are interested in gathering more information to better keep track of patient treatment patterns (trends) that may differ from physician to physician, hospital to hospital, medication to medication, patient to patient and if necessary, procedure to procedure.

Detailed Description

The objective of this research is to establish a contemporary and simple to construct AF management registry that expands progressively over the continuum of care for each individual patient. The registry will be used to determine the course and progression of AF management in preventing thrombo-embolic events using rhythm and rate control interventions. Primary endpoints: 1. Atrial fibrillation natural history 2. Thrombo-embolic event 3. Death Secondary endpoints: 1. Bleeding 2. Pro-arrhythmia 3. Patient adherence 4. Treatment complication

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. Diagnosis of valvular or non valvular atrial fibrillation 2. ECG documented atrial fibrillation A. 12 lead B. Rhythm strip C. Event monitor D. Holter Monitor E. Implantable loop recorder Exclusion Criteria: 1. Age below 18 years. 2. Clinical evidence that death within 6 months is possible 3. Inability to consent to the research or sign a consent form 4. Inability to follow up at the research clinic at least annually for continuity of AF care and management

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Atrial Fibrillation

Locations

CorVita Science Foundation (NFP)

Chicago, Illinois 60605

United States